Cannabis Report above an image of cannabis
(Source: file)

Aurora Cannabis Inc., a Canadian-based global medical cannabis company, announces an investment over five years into operational upgrades at its EU-GMP manufacturing facility in Leuna, Germany. Building on best practices proven at Aurora’s Canadian facilities, these improvements will increase flower growth capacity, product quality and drive cost efficiency.

(Source: Aurora Cannabis Inc.)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | High Tide to open three New Canna Cabana locations across Ontario and Alberta

2 | MTL Cannabis Corp. closes of $2 Million brokered offering

3 | Cannabix Technologies to participate at U.S. National Institute of Standards and Technology Cannabis Breathalyzer Workshop


Top Cannabis Stocks Sept. 19. to Sept. 25, 2025

1. T.TLRY | 5,889 views | Tilray Brands Inc.
2. T.CURA| 4,343 views | Curaleaf Holdings Inc.
3. T.WEED | 2,398 views | Canopy Growth Corp.
4. T.LABS | 1,509 views | Medipharm Labs Corp.
5. C.BKTS | 588 views | Beckett’s Inc.
6. C.TGIF | 571 views | 1933 Industries Inc.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.


More From The Market Online

@ the Bell: TSX lifted by strong earnings from Big Six banks

The TSX Index added more than 1 per cent on Thursday driven by strong earnings from Canada’s Big Six banks.

Market Open: Salesforce Gains, EQB Buys PC Financial, Copper Slips | Dec 04, 2025

TSX rises 0.36% as Salesforce jumps 2% and EQB acquires PC Financial. Dow dips, gold edges higher, copper and Bitcoin fall.

Buzz on the Bullboards: Cannabis stock split, major financing, and battery breakthrough

Inflation concerns, lofty valuations, and growing uncertainty around returns from have prompted investors to reassess their AI exposure.